Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

lebrikizumab-lbkz

lebrikizumab-lbkz
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Ebglyss INJECTION, SUBCUTANEOUS 125 mg/mL      


Comments:

Non-formulary. Ebglyss is only distributed via specialty pharmacy directly to the patient and is not orderable by the hospital.

 

 

 

Reviewed: July 2025       

 

Lebrikizumab-lbkz (Ebglyss) Spotlight.pdf    


Last updated: Jul. 31, 2025







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.